People · Operator
Named in public records as an officer, director or promoter · active 2014–2026 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sensei Biotherapeutics, Inc. | — | Biotechnology | Series D+ | $348.9M | $2.2B | 2026 |
| Tectonic Therapeutic, Inc. | — | Biotechnology | Series D+ | $333.1M | $1.7B | 2025 |
| Taysha Gene Therapies, Inc. | — | Biotechnology | Series D+ | $294.0M | $2.2B | 2022 |
| Eoshealth, Inc. | — | Other Health Care | Series A | $8.2M | $165.5M | 2014 |
PHILLIP B. DONENBERG at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PHILLIP B. DONENBERG on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Booth | 1 | 12 |
| Glen Tullman | 1 | 12 |
| Joshua Resnick | 1 | 12 |
| LEE SHAPIRO | 1 | 10 |
| Terry McGuire | 1 | 8 |
| Paul B. Manning | 1 | 6 |
| Ian Clark | 1 | 5 |
| Scott Requadt | 1 | 5 |
| Timothy A. Springer | 1 | 4 |
| Christopher Mason | 1 | 3 |
| Sean Nolan | 1 | 3 |
| Andrew Kruse | 1 | 2 |
| Katina Dorton | 1 | 2 |
| JOSEPH E. CAREY | 1 | 2 |
| Praveen P. Tipirneni | 1 | 2 |
| Sean P. Nolan | 1 | 2 |
| Stefan A. Vitorovic | 1 | 1 |
| Christian A. Cortis | 1 | 1 |
| Christopher Paige | 1 | 1 |
| ROBERT C. CONTE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.